Duplicate Document
This document appears to be a copy. The original version is:
EFTA Document EFTA01493457Case File
efta-efta01493457DOJ Data Set 10CorrespondenceEFTA Document EFTA01493457
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01493457
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Summary
Ask AI About This Document
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
FINANCIAL TRUST COMPANY INC ACCT.
For the Period 9/1/12 to 9/30/12
Note
P indicates position adjusted for Pending Trade Activity.
Unrealized GainiLoss is shown as "N A" in cases where we do not have appropriate cost information for all lax lots comprising the position. Please contact your J P Morgan team for additional
information.
Equity Detail
Pike
Quantity
Value
Adjusted Tax Cost
Unrealized
Gain/Loss
Est. Annual Inc
Yield
Original Cost
Accrued Div.
US Large Cap Equity
ARIAD PHARMACEUTICALS INC
24.21
16,535.000
400,312.35
251,475.52
148,836.83
04033A-10-0 ARIA
BIOGEN IDEC INC
149.21
2,095.000
312.594.95
250,454.95
62,140.00
09062X-10-3 BIIB
FACEBOOK INC-A
21.66
17.500 003
379.050.00
665,000 00
(285,950.00)
30303M-10-2 FB
Total US Large Cap Equity
$1,091,967.30
31,166,930.47
(574.973.17)
30.00
0.00%
US Small Cap Equity
P PENNANTPARK INVESTMENT CORP
10 61
0.00
10.56%
708062-10-4 PNNT
US Small/Mid Cap Equity
P CASELLA WASTE SYSTEMS INC
4.27
0.00
CL A
147448-10-4 CWST
JP Morgan
Account
Page 5 of 36
Consolidated Statement Page 9
Confidential Treatment Requested by JPMorgan
Chase
CONFIDENTIAL
JPM-SDNY-00016320
SONY GM_00285518
EFTA01493457
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.
Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.